Activities, Bill Numbers and Titles
|
|
Client: Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
Senate Docket
|
2264
|
An Act to create a Massachusetts rare disease advisory council
|
Support
|
$450.00
|
N/A
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Oppose
|
$1,620.00
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$1,080.00
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Oppose
|
$1,080.00
|
N/A
|
House Bill
|
1934
|
An Act to create a Massachusetts rare disease advisory council
|
Support
|
$450.00
|
N/A
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Value Based Contracts, Group Insurance Commission
|
Support
|
$900.00
|
N/A
|
| | |
Total amount
|
$5,580.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|